These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 1834933)
21. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO Menopause; 2005; 12(4):468-74. PubMed ID: 16037763 [TBL] [Abstract][Full Text] [Related]
22. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Ree AH; Landmark BF; Eskild W; Levy FO; Lahooti H; Jahnsen T; Aakvaag A; Hansson V Endocrinology; 1989 May; 124(5):2577-83. PubMed ID: 2651098 [TBL] [Abstract][Full Text] [Related]
23. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. Herman ME; Katzenellenbogen BS J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641 [TBL] [Abstract][Full Text] [Related]
25. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257 [TBL] [Abstract][Full Text] [Related]
26. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Nomura Y; Tashiro H; Takaeko F Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351 [TBL] [Abstract][Full Text] [Related]
27. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines. Müller V; Jensen EV; Knabbe C Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403 [TBL] [Abstract][Full Text] [Related]
28. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Hyder SM; Murthy L; Stancel GM Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078 [TBL] [Abstract][Full Text] [Related]
29. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor. Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561 [TBL] [Abstract][Full Text] [Related]
30. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295 [TBL] [Abstract][Full Text] [Related]
31. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
32. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. Mirkin S; Wong BC; Archer DF Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894 [TBL] [Abstract][Full Text] [Related]
33. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Seeger H; Wallwiener D; Mueck AO Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785 [TBL] [Abstract][Full Text] [Related]
34. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106 [TBL] [Abstract][Full Text] [Related]
35. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. Chen FP; Chien MH; Chen HY; Huang TS; Ng YT Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375 [TBL] [Abstract][Full Text] [Related]
36. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells. Reiner GC; Katzenellenbogen BS Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090 [TBL] [Abstract][Full Text] [Related]
37. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. Vignon F; Bardon S; Chalbos D; Rochefort H J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424 [TBL] [Abstract][Full Text] [Related]
38. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. Schoonen WG; Joosten JW; Kloosterboer HJ J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):439-44. PubMed ID: 8541241 [TBL] [Abstract][Full Text] [Related]
39. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer. Brandt S; Kopp A; Grage B; Knabbe C Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217 [TBL] [Abstract][Full Text] [Related]
40. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen. Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]